Skip to Content

KU 181 (Pantoprazole sodium delayed release 40 mg)

Pill imprint KU 181 has been identified as Pantoprazole sodium delayed release 40 mg.

Pantoprazole is used in the treatment of gerd; barrett's esophagus; dumping syndrome; erosive esophagitis; zollinger-ellison syndrome (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 40 mg is not subject to the Controlled Substances Act.

See also related documents.

Pantoprazole sodium delayed release 40 mg KU 181
Pantoprazole sodium delayed release
KU 181
40 mg
Elliptical / Oval
Prescription only
Drug Class:
Proton pump inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Kremers Urban
National Drug Code (NDC):
Inactive Ingredients:
ferrosoferric oxide
glyceryl dibehenate
isopropyl alcohol
lactose monohydrate
propylene glycol
magnesium silicate
titanium dioxide
triethyl citrate
methacrylic acid - methyl methacrylate copolymer (1:1)

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.